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ABSTRACT
Fibromodulin is an extracellular matrix protein normally produced by collagen-rich tissues. By studying the global gene expression profile of B-cell chronic lymphocytic leukemia (B-CLL) cells, fibromodulin was found to be the most over-expressed (>300-2200 times) gene 1, 2 .
In this study, fibromodulin was found to be expressed at the gene level (RT-PCR) in all B-CLL patients (n=75) and in the majority (5/7) of patients with mantle cell lymphoma (MCL) . No mutations in the fibromodulin gene were detected.
Fibromodulin was also detected at the protein level in the cytoplasm of the B-CLL cells and in the supernatant following in vitro cultivation, but not at the cell surface. Similarly, endothelial cells have the capacity to protect B-CLL cells from apoptosis by means of physical interaction 7 . Viability of B-CLL cells cultured on fibronectin is consistently higher than the viability of control cultures 8 . It has been suggested that direct cell-cell contact and/or matrix or membrane-bound cytokines rather than soluble factors may be important for the in vivo survival of B-CLL cells 9 . Bidirectional malignant lymphocyte-microenvironment interactions may lead to the amplification of a micro-environment able to inhibit apoptosis of B-CLL cells.
Over-expression of numerous genes has been shown using microarray technique including a marked increase of fibromodulin (>300-2200 times) 1, 2 . Fibromodulin (42 -80 kD) is a member of the extracellular class II leucin-rich proteoglycan family involved in the regulation of the assembly of collagen in connective tissues 10, 11 . It is a cytosolic protein with a secretory sequence but no transmembrane or extracellular domain. Although fibromodulin has so far been ignored as a molecule, which may be involved in the pathogenesis of cancer, it has become evident that this and other members of the proteoglycan family are not only involved in collagen fibrillogenesis and cell adhesion but also contribute to the modulation of cytokine activity, tumor growth suppression and prevention of apoptosis [12] [13] [14] [15] . Sulfation of tyrosine residues at the N-terminal part of fibromodulin indicates that fibromodulin might be involved in chemokine receptor signaling 16 .
In the present study, we extended our preliminary finding 17 and could now demonstrate that fibromodulin is a rather unique, non-mutated molecule selectively 
MATERIALS AND METHODS
PATIENTS AND CONTROLS
The WHO Classifications of Neoplasms of the Hematopoetic and Lymphoid Tissues were applied 18 . Heparinized peripheral blood was collected from the patients with B-CLL (n=75) as well as from MCL (n=7), T cell chronic lymphocytic leukemia (T-CLL) (n=5), hairy cell leukemia (HCL) (n=10), B-cell prolymphocytic leukemia (B-PLL) (n=1), T cell prolymphocytic leukemia (T-PLL) (n=1), chronic myelogenous leukemia (CML) (n=15), acute myelogenous leukemia (AML) (n=5), acute lymphoblastic leukemia (ALL) (n=14). Bone marrow tumor cells were obtained from patients with B-CLL (n=2), multiple myeloma (n=4), follicular lymphoma (n=2), and lymphoplasmacytic lymphoma (n=4).
Control blood was drawn from normal healthy donors (n=70) with a mean age of 38 years (range 19-75). Fresh human tonsils were obtained from two children after routine tonsilectomy. This study was approved by the Ethics Committee of each institution and informed consent was obtained from all patients in accordance with the Helsinki declaration.
HEMATOLOGICAL AND FIBROBLAST CELL LINES
Thirty-six cell lines derived from a variety of hematological tumors were also included (see Table 3 ). Characteristics of the Burkitt's lymphoma cell lines have been described previously 19 . One B-CLL cell line (EHEB) Scotland) supplemented with 10% fetal bovine serum (FBS) (Gibco), L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml) (Gibco) (complete medium).
ISOLATION OF PERIPHERAL BLOOD CELLS
Normal peripheral blood mononuclear cells (PBMC) (lymphocytes and monocytes), blood tumor cells and bone marrow tumor cells were isolated from blood or bone marrow respectively using Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) density 7 gradient centrifugation as earlier described 22 . Granulocytes were recovered from the top of the erythrocyte layer after Ficoll density gradient centrifugation. Erythrocytes were lysed by hypo-osmosis in cold water. More than 98% of the nucleated cells were granulocytes. Tonsil tissue was cut and passed through a metal grid and suspension of tonsil mononuclear cells was prepared by Ficoll-Hypaque density gradient centrifugation as earlier described 22 .
ISOLATION OF B AND T CELLS
PBMC from healthy donors were isolated as described above. T and B lymphocytes were purified by negative selection using MACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to manufacturer's instruction. The purity of the Leukemic B cells and tonsil mononuclear cells were also enriched using nylon wool purification 22 .
ACTIVATION OF NORMAL B AND T LYMPHOCYTES, TONSIL B CELLS AND B-CLL CELLS
Stable CD40L transfected mouse fibroblast cells (NIH-3T3) were irradiated (100 Gy) and transferred to 6-well plates (TPP, Trasadingen, Switzerland) (150 000 cells/well) in RPMI-1640 medium supplemented with 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml) and L-Glutamine (2 mM). After overnight incubation at 37°C in humified air with 5% CO 2 fibroblasts were washed in PBS. Isolated normal B-lymphocytes, tonsil B cells and B-CLL cells were added (4 x 10 6 cells/well) and cultured in a total volume of 2 ml of DMEM medium (no. 41965) (Gibco) supplemented with 10% FBS, penicillin, streptomycin and L-Glutamine at 37°C in humified air with 5% CO 2 for 48 h. Cells cultured in medium alone were used as a control.
Isolated T-lymphocytes were stimulated with anti-CD3 antibody (OKT3) (30 ng/ml) (Mabtech, Stockholm, Sweden) using the same culture condition as above. 
ACTIVATION OF B-CLL CELL LINES
Under standard condition the two B-CLL cell lines EHEB and I83-E95 were continously cultured in RPMI-1640 (Gibco) supplemented with penicillin, streptomycin, L-Glutamine and 10% FBS. Cells in RPMI-1640 were stimulated by coculture with irradiated CD40L transfected fibroblasts (see above). EHEB cells were also stimulated with 25 ng/ml PMA + 1 µg/ml ionomycin.
Both B-CLL cell lines were also cultured in DMEM medium supplemented with penicillin (100 U/ml), streptomycin (100 µg/ml), L-Glutamine (2 mM) and 10% FBS (unstimulated) as well as stimulated with 20 ng/ml PMA + 1 µg/ml ionomycin for 48
h. After 48 h of culture cells were harvested. Activation was tested by measuring the expression of CD25 and CD69 using monoclonal antibodies (B-D) and flow cytometry. RNA was isolated, cDNA was prepared and the relative increase in fibromodulin expression compared to unstimulated time 0 h was determined by realtime PCR (see below).
TRANSFORMATION OF NORMAL B-CELLS WITH EPSTEIN-BARR VIRUS (EBV)
EBV transformation was performed as previously described 23 . Briefly, purified B lymphocytes (2x10 and streptomycin (100 µg/ml). 
REAL-TIME QUANTITATIVE PCR (RT-QPCR)
cDNA samples were used as template and W-actin (endogenous housekeeping gene) was quantified as a positive control against which the different template values were normalized. For W-actin the sense primer was 5'-CGACAGGATGCAGAAGGAGA- Surface-staining for membrane-bound fibromodulin was performed in indirect immunofluorescence using the same primary and secondary antibodies as above.
WESTERN BLOT
PBMC were lysed in buffer containing 2% Triton X-100, 10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM NaF, 20 mM Na4P2O7, 1% Glycerol, 0.1% SDS and Trasadingen, Switzerland) in 2 ml of AIM-V medium (Gibco) supplemented with penicillin (100 U/ml), streptomycin (100 µg/ml) and L-glutamine (2 mM) at 37°C in humified air with 5% CO 2 . After culturing, supernatants were harvested and analysed by western blot using the same antibodies and conditions as above. Purified fibromodulin control protein was a kind gift from Prof D. Heinegård.
For
MUTATION ANALYSIS OF THE FIBROMODULIN GENE
PBMC from healthy individuals and B-CLL patients were isolated and subjected to RNA and genomic DNA preparation as previously described 26 . Fibromodulin was not expressed in fresh PBMC (lymphocytes and monocytes) of healthy donors (n=70), isolated normal B cells (purity >90%) (n=6), isolated tonsil B cells (purity >90%) (n=2), isolated T cells (purity >70%) (n=4) and isolated blood granulocytes (purity >98%) (n=10). Normal blood T lymphocytes *** 0/4 * purity >90%; ** purity >98% *** purity >70% 
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MUTATION ANALYSIS OF THE FIBROMODULIN GENE IN HEALTHY INDIVIDUALS AND B-CLL PATIENTS
To determine mutations in the coding region of the fibromodulin gene giving rise to Fibromodulin is a cytosolic secreted protein with a restricted expression pattern mainly to cartilage, bone, connective tissues and tissues rich in collagen 25 .
Fibromodulin is involved in fibrillogenesis, cell adhesion and modulation of cytokine activity. This raises the idea of involvement of fibromodulin in tumor suppression and prevention of apoptosis as for other proteoglycans like decorin [12] [13] [14] [15] . In normal tissues fibromodulin seems to be developmentally regulated with higher levels of expression early in life and decreased expression during aging 32 . Fibromodulin knock-out mice demonstrated collagen malformation and symptoms resembling osteoarthritis but no life-threatening structural or physiological defects were observed 33, 34 .
Over-expression of ECM proteins has been observed in malignant cells [35] [36] [37] but the underlying mechanisms are poorly understood. ECM may promote angiogenesis 38 .
ECM might interact with cell surface associated heparan sulfate proteoglycans and regulate proliferation and angiogenesis 39 . Myeloma cells express the heparan sulfate proteoglycan, syndecan-1, which is a receptor for the hepatocyte growth factor, which may act as a growth factor for myeloma cells . Cell-cell as well as cellmatrix interactions have been shown to be critical events in preventing apoptosis of malignant lymphocytes. In B-CLL, direct contact between leukemic and bone marrow stromal cells have been found to be essential for tumor cell survival 6, 44 . Bone marrow Resistance of B-CLL cells to pro-apoptotic and anti-proliferative effects of transforming growth factor beta (TGF-) has earlier been reported [45] [46] [47] . TGF-is secreted by B-CLL cells, without a significant inhibitory effect on the leukemic B cells which is not the case for normal B-cells where autocrine produced TGFinhibits differentiation and proliferation 45 . These results may suggest an adaptation of the anti-apoptotic mechanisms of TGF-in B-CLL cells. Resistance to the inhibitory effects of TGF-has been suggested to be associated with loss of TGF-receptors 46 , which has not been confirmed by others 45, 48 , indicating other mechanisms as well.
Fibromodulin has been shown to modulate and suppress TGF-functions in vivo and in vitro 12 . Fibromodulin has binding sites for TGF-and binding of TGF-to fibromodulin in B-CLL may inhibit the apoptotic activity of TGF-.
The two B-CLL cell lines did not express fibromodulin when cultured in standard RPMI medium and no effect of CD40L or PMA/ionomycin activation was noted.
However, when cultured in DMEM medium, fibromodulin expression was induced which was further enhanced by PMA/ionomycin activation. DMEM medium has a higher glucose concentration than RPMI-1640 and contains Fe(NO 3 ). Glucose and iron have been reported to induce TGF-W production 49, 50 . Iron is of importance for the expression of cell-cycle and apoptosis related genes 
